Image OHSU receiving a shipment of Pfizer BioNTEch COVID-19 vaccine. | OHSU/FRITZ LIEDTKE OHSU Anticipates Revenue Growth, Modest Profit In Coming Fiscal Year Oregon’s flagship health care facility reports strong investment income and investment portfolio growth help to provide a backstop as expenses rise. Apr 15, 2021 Premium Subscribe to derick du vivier